AssistRx Enhances Therapy Initiation Solutions with Non-Commercial Specialty Pharmacy
November 05, 2019 10:00 ET
|
AssistRx
ORLANDO, Fla., Nov. 05, 2019 (GLOBE NEWSWIRE) -- AssistRx, the intelligent specialty therapy initiation and patient support company, today announced the launch of its non-commercial specialty...
AssistRx Appoints Jan Nielsen as Division President of Patient Solutions Business
September 10, 2019 09:30 ET
|
AssistRx
ORLANDO, Fla., Sept. 10, 2019 (GLOBE NEWSWIRE) -- AssistRx, the intelligent specialty therapy initiation and patient support company, announced today the appointment of Jan Nielsen as division...
BioDelivery Sciences Announces Upcoming Investor Conference Presentations
May 29, 2019 16:10 ET
|
BioDelivery Sciences International, Inc.
RALEIGH, N.C., May 29, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients...
BioDelivery Sciences Strengthens Financial Position with Debt Refinancing
May 28, 2019 16:10 ET
|
BioDelivery Sciences International, Inc.
New Agreement is Cash Flow Accretive, Lowers Cost of Capital and Extends Debt Maturity Reduces Annual Interest Costs by Approximately $1.5 million Increases Flexibility to Continue Growth Trajectory...
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2019 Ended December 31, 2018 and Provides Conference Call Information
February 11, 2019 17:34 ET
|
Elite Pharmaceuticals, Inc.
Conference Call Scheduled for Tuesday, February 12th at 11:30 AM EST NORTHVALE, N.J., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP), a...
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2019 Financial Results on February 12, 2019
February 07, 2019 06:00 ET
|
Elite Pharmaceuticals, Inc.
Northvale, NJ, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB: ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent...
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2019 Ended September 30, 2018 and Provides Conference Call Information
November 09, 2018 16:45 ET
|
Elite Pharmaceuticals, Inc.
Conference Call Scheduled for Monday, November 12th at 11:30 AM EST NORTHVALE, N.J., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP), a...
Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study
August 14, 2018 07:48 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and...
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2019 Ended June 30, 2018 and Provides Conference Call Information
August 09, 2018 16:43 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and...
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2019 Financial Results on August 10, 2018
August 07, 2018 16:00 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB: ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent...